BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29610366)

  • 1. Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation.
    Zhu Q; Yan L; Liu Q; Zhang C; Wei L; Hu Q; Preus L; Clay-Gilmour AI; Onel K; Stram DO; Pooler L; Sheng X; Haiman CA; Zhu X; Spellman SR; Pasquini M; McCarthy PL; Liu S; Hahn T; Sucheston-Campbell LE
    Blood; 2018 May; 131(22):2490-2499. PubMed ID: 29610366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
    Pidala J; Lee SJ; Ahn KW; Spellman S; Wang HL; Aljurf M; Askar M; Dehn J; Fernandez Viña M; Gratwohl A; Gupta V; Hanna R; Horowitz MM; Hurley CK; Inamoto Y; Kassim AA; Nishihori T; Mueller C; Oudshoorn M; Petersdorf EW; Prasad V; Robinson J; Saber W; Schultz KR; Shaw B; Storek J; Wood WA; Woolfrey AE; Anasetti C
    Blood; 2014 Oct; 124(16):2596-606. PubMed ID: 25161269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Marrow Transplant Research Study.
    Askar M; Sobecks R; Wang T; Haagenson M; Majhail N; Madbouly A; Thomas D; Zhang A; Fleischhauer K; Hsu K; Verneris M; Lee SJ; Spellman SR; Fernández-Viña M
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):436-444. PubMed ID: 27987385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant.
    Karaesmen E; Rizvi AA; Preus LM; McCarthy PL; Pasquini MC; Onel K; Zhu X; Spellman S; Haiman CA; Stram DO; Pooler L; Sheng X; Zhu Q; Yan L; Liu Q; Hu Q; Webb A; Brock G; Clay-Gilmour AI; Battaglia S; Tritchler D; Liu S; Hahn T; Sucheston-Campbell LE
    Blood; 2017 Sep; 130(13):1585-1596. PubMed ID: 28811306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of donor IFNL4 genotype and non-relapse mortality after unrelated donor myeloablative haematopoietic stem-cell transplantation for acute leukaemia: a retrospective cohort study.
    Gadalla SM; Wang Y; Wang T; Onabajo OO; Banday AR; Obajemu A; Karaesman E; Sucheston-Campbell L; Hahn T; Sees JA; Spellman SR; Lee SJ; Katki HA; Prokunina-Olsson L
    Lancet Haematol; 2020 Oct; 7(10):e715-e723. PubMed ID: 32976751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia.
    Segal E; Martens M; Wang HL; Brazauskas R; Weisdorf D; Sandmaier BM; Khoury HJ; de Lima M; Saber W
    Cancer; 2017 Sep; 123(17):3346-3355. PubMed ID: 28452054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.
    Konuma T; Tsukada N; Kanda J; Uchida N; Ohno Y; Miyakoshi S; Kanamori H; Hidaka M; Sakura T; Onizuka M; Kobayashi N; Sawa M; Eto T; Matsuhashi Y; Kato K; Ichinohe T; Atsuta Y; Miyamura K;
    Am J Hematol; 2016 May; 91(5):E284-92. PubMed ID: 26910296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The recipient CXCL10 + 1642C>G variation predicts survival outcomes after HLA fully matched unrelated bone marrow transplantation.
    Nakata K; Takami A; Espinoza JL; Matsuo K; Morishima Y; Onizuka M; Fukuda T; Kodera Y; Akiyama H; Miyamura K; Mori T; Nakao S;
    Clin Immunol; 2013 Feb; 146(2):104-11. PubMed ID: 23291247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia.
    Zheng C; Zhu X; Tang B; Yao W; Song K; Tong J; Geng L; Liu H; Sun Z
    Ann Hematol; 2015 Mar; 94(3):473-80. PubMed ID: 25217231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies.
    Espinoza LJ; Takami A; Nakata K; Yamada K; Onizuka M; Kawase T; Sao H; Akiyama H; Miyamura K; Okamoto S; Inoue M; Fukuda T; Morishima Y; Kodera Y; Nakao S;
    PLoS One; 2011; 6(8):e23827. PubMed ID: 21886827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
    Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.
    Woolfrey A; Klein JP; Haagenson M; Spellman S; Petersdorf E; Oudshoorn M; Gajewski J; Hale GA; Horan J; Battiwalla M; Marino SR; Setterholm M; Ringden O; Hurley C; Flomenberg N; Anasetti C; Fernandez-Vina M; Lee SJ
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):885-92. PubMed ID: 20870028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission.
    Nishiwaki S; Terakura S; Yasuda T; Imahashi N; Sao H; Iida H; Kamiya Y; Niimi K; Morishita Y; Kohno A; Yokozawa T; Ohashi H; Sawa M; Kodera Y; Miyamura K
    Int J Hematol; 2010 Apr; 91(3):419-25. PubMed ID: 20146028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cord blood transplantation with unrelated bone marrow transplantation in patients older than fifty years.
    Tanaka M; Miyamura K; Terakura S; Imai K; Uchida N; Ago H; Sakura T; Eto T; Ohashi K; Fukuda T; Taniguchi S; Mori S; Nagamura-Inoue T; Atsuta Y; Okamoto S
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):517-25. PubMed ID: 25498906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cord-Blood Transplantation in Patients with Minimal Residual Disease.
    Milano F; Gooley T; Wood B; Woolfrey A; Flowers ME; Doney K; Witherspoon R; Mielcarek M; Deeg JH; Sorror M; Dahlberg A; Sandmaier BM; Salit R; Petersdorf E; Appelbaum FR; Delaney C
    N Engl J Med; 2016 Sep; 375(10):944-53. PubMed ID: 27602666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia.
    Schetelig J; Baldauf H; Koster L; Kuxhausen M; Heidenreich F; de Wreede LC; Spellman S; van Gelder M; Bruno B; Onida F; Lange V; Massalski C; Potter V; Ljungman P; Schaap N; Hayden P; Lee SJ; Kröger N; Hsu K; Schmidt AH; Yakoub-Agha I; Robin M
    Front Immunol; 2020; 11():584520. PubMed ID: 33542712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program.
    Castro-Malaspina H; Harris RE; Gajewski J; Ramsay N; Collins R; Dharan B; King R; Deeg HJ
    Blood; 2002 Mar; 99(6):1943-51. PubMed ID: 11877264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J
    Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.
    Eapen M; Rocha V; Sanz G; Scaradavou A; Zhang MJ; Arcese W; Sirvent A; Champlin RE; Chao N; Gee AP; Isola L; Laughlin MJ; Marks DI; Nabhan S; Ruggeri A; Soiffer R; Horowitz MM; Gluckman E; Wagner JE; ; ;
    Lancet Oncol; 2010 Jul; 11(7):653-60. PubMed ID: 20558104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrelated donor or autologous marrow transplantation for treatment of acute leukemia.
    Busca A; Anasetti C; Anderson G; Appelbaum FR; Buckner CD; Doney K; Martin PJ; Petersdorf E; Sanders JE; Hansen JA
    Blood; 1994 May; 83(10):3077-84. PubMed ID: 8180404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.